Inactive Instrument

Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE

Equities

IL0006290147

Pharmaceuticals

Sales 2024 * 15.86B 5,976B Sales 2025 * 16.35B 6,158B Capitalization 14.83B 5,587B
Net income 2024 * 1.54B 579B Net income 2025 * 1.44B 543B EV / Sales 2024 * 1.86 x
Net Debt 2024 * 14.62B 5,509B Net Debt 2025 * 12.12B 4,566B EV / Sales 2025 * 1.65 x
P/E ratio 2024 *
10.6 x
P/E ratio 2025 *
9.89 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.57%
More Fundamentals * Assessed data
Dynamic Chart
Teva Pharmaceutical Unit Says Late-Stage Trial in China of Ajovy to Prevent Migraine Achieves Primary, Secondary Endpoints MT
Teva Confirms Efficacy and Safety of AJOVY for the Prevention of Migraine with Results from Phase 3 Trial in China CI
Teva Pharmaceuticals International, mAbxience Sign Licensing Deal for Oncology Biosimilar Candidate MT
UroGen Pharma Sues Teva Pharmaceuticals Over Alleged Patent Infringement of Jelmyto MT
US Appellate Court Vacates Ruling Maintaining Johnson & Johnson's Schizophrenia Drug Patent; Sends Back for Review MT
US Appellate Court Vacates Ruling Maintaining Johnson & Johnson's Schizophrenia Drug Patent; Sends Back for Review MT
Teva Pharmaceutical to Get $150 Million From Carlyle Group's Abingworth for Asthma Therapy With Launch Therapeutics MT
JPMorgan Upgrades Teva Pharmaceutical Industries to Neutral From Underweight, Adjusts Price Target to $14 From $11 MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $657,240, According to a Recent SEC Filing MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,048,119, According to a Recent SEC Filing MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,352,090, According to a Recent SEC Filing MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $414,270, According to a Recent SEC Filing MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,277,207, According to a Recent SEC Filing MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $270,176, According to a Recent SEC Filing MT
Global markets live: Domino's Pizza, Walt Disney, Broadcom, Ryanair, Exxon Mobil, Goldman Sachs... Our Logo
More news

Latest transcript on Teva Pharmaceutical Industries Limited

Managers TitleAgeSince
Chief Executive Officer 55 22-12-31
Director of Finance/CFO 51 19-12-21
Chief Tech/Sci/R&D Officer - 22-07-31
Members of the board TitleAgeSince
Director/Board Member 77 15-08-31
Director/Board Member 60 20-06-08
Chairman 76 14-12-31
More insiders
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Calendar
More about the company